16 Recruiting Studies Using Cediranib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Cediranib
Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours
📍 Research Site — Edmonton, Alberta
Solid Tumors
View Study & Checklist ➔Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
Recurrent Glioblastoma
View Study & Checklist ➔Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Fallopian Tube Clear Cell Adenocarcinoma
View Study & Checklist ➔Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
📍 Cedars-Sinai Medical Center — Los Angeles, California
Fallopian Tube Carcinoma
View Study & Checklist ➔Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Fallopian Tube Clear Cell Adenocarcinoma
View Study & Checklist ➔Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
📍 Mayo Clinic in Florida — Jacksonville, Florida
Metastatic Melanoma
View Study & Checklist ➔Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
📍 Research Site — Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer
📍 UC San Diego Moores Cancer Center — La Jolla, California
Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation
View Study & Checklist ➔Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
📍 Highlands Oncology Group - Rogers — Rogers, Arkansas
Epithelioid Mesothelioma
View Study & Checklist ➔Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Endometrial Adenocarcinoma
View Study & Checklist ➔Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Colorectal Neoplasms
View Study & Checklist ➔Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Mismatch Repair Proficient Colorectal Cancer
View Study & Checklist ➔Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Fallopian Tube Mucinous Adenocarcinoma
View Study & Checklist ➔A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
📍 UC San Diego Moores Cancer Center — La Jolla, California
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Fallopian Tube Carcinoma
View Study & Checklist ➔Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Breast Carcinoma
View Study & Checklist ➔